Effect of High-dose Mucosolvan Applied to the elderly Patients with Severe Pneumonia

Objective To study the effects of the high-dose mucosolvan on the elderly patients with severe pneumonia. Methods 60 elder patients with severe pneumonia were randomly divided into two groups. The treatment group was administered continuous intravenous drip of high-dose mucosolvan (500 mg each time, two times a day for 7 days), and the control group was administered continuous intravenous drip of routine-dose mucosolvan (30 mg each time, three times a day for 7 days). Both groups were applied to oxygen, eliminate sputum and antibiotics. The blood gas, clinical symptoms and signs were analyzed. Results The clinical manifestations and blood gas analysis in the treatment group were better than the control group (P 0.05). Conclusions High-dose mucosolvan on elderly patients with severe pneumonia earlier is safe and effective, which can prevent the diasese from worsening, and deserves clinical application.